Physician profile
Mark Clinger
NPI 1699769471
$2,472.78
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,383 · 2020: $220 · 2021: $261 · 2022: $526 · 2023: $82.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $341.60 | 2019-2020 | |
| Abbvie INC. | $321.78 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $263.83 | 2019-2022 | |
| Pfizer INC. | $238.12 | 2019-2022 | |
| Abbott Laboratories | $184.02 | 2020-2022 | |
| Allergan, INC. | $132.56 | 2019 | |
| Novo Nordisk INC | $96.38 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $93.14 | 2019-2020 | |
| Boston Scientific Corporation | $82.57 | 2023 | |
| Lilly USA, LLC | $79.16 | 2019-2022 | |
| Astellas Pharma US INC | $77.75 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $65.05 | 2019-2022 | |
| Antares Pharma, INC. | $60.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $60.46 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.83 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $54.37 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $47.29 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.36 | 2019-2022 | |
| Stryker Corporation | $22.14 | 2019 | |
| Radius Health, INC. | $21.83 | 2019 | |
| Mylan Specialty L.P. | $21.65 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.81 | 2022 | |
| Amarin Pharma, INC. | $17.89 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.88 | 2019 | |
| Organon LLC | $15.02 | 2022 | |
| Lucid Diagnostics INC. | $14.95 | 2022 | |
| Ironwood Pharmaceuticals, INC | $14.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Clinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.